Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 12 » default
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4097)
- Volume 19, 2023 (240)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 12, 2016
Association between the high-dose use of benzodiazepines and rehospitalization in patients with schizophrenia: a 2-year naturalistic study
Takita Y, Takaesu Y, Ono K, Futenma K, Shimura A, Murakoshi A, Komada Y, Inoue Y, Inoue T
Neuropsychiatric Disease and Treatment 2016, 12:3243-3247
Published Date: 15 December 2016
Impact of parental presence during induction of anesthesia on anxiety level among pediatric patients and their parents: a randomized clinical trial
Sadeghi A, Khaleghnejad Tabari A, Mahdavi A, Salarian S, Razavi SS
Neuropsychiatric Disease and Treatment 2016, 12:3237-3241
Published Date: 20 February 2017
Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
Okuyama Y, Oya K, Matsunaga S, Kishi T, Iwata N
Neuropsychiatric Disease and Treatment 2016, 12:3221-3236
Published Date: 15 December 2016
Drug therapy of epileptic seizures among adult epileptic outpatients of University of Gondar Referral and Teaching Hospital, Gondar, North West Ethiopia
Birru EM, Shafi M, Geta M
Neuropsychiatric Disease and Treatment 2016, 12:3213-3219
Published Date: 16 December 2016
Incidence, risk factors, and phenomenological characteristics of postoperative delirium in patients receiving intravenous patient-controlled analgesia: a prospective cohort study
Lin YT, Lan KM, Wang LK, Chu CC, Wu SZ, Chang CY, Chen JY
Neuropsychiatric Disease and Treatment 2016, 12:3205-3212
Published Date: 13 December 2016
Non-24-hour sleep–wake syndrome improved by low-dose valproic acid: a case report
Kurita M, Moriya T, Nishino S, Hirata E, Hirasawa N, Okubo Y, Sato T
Neuropsychiatric Disease and Treatment 2016, 12:3199-3203
Published Date: 13 December 2016
Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities
Okazaki K, Makinodan M, Yamamuro K, Takata T, Kishimoto T
Neuropsychiatric Disease and Treatment 2016, 12:3195-3198
Published Date: 14 December 2016
Neuroprotection and acidosis induced by cortical spreading depression
Kwong KK, Chan ST
Neuropsychiatric Disease and Treatment 2016, 12:3191-3194
Published Date: 12 December 2016
Associations between the mismatch-negativity component and symptom severity in children and adolescents with attention deficit/hyperactivity disorder
Yamamuro K, Ota T, Iida J, Nakanishi Y, Kishimoto N, Kishimoto T
Neuropsychiatric Disease and Treatment 2016, 12:3183-3190
Published Date: 12 December 2016
The impact of residual symptoms on relapse and quality of life among Thai depressive patients
Hiranyatheb T, Nakawiro D, Wongpakaran T, Wongpakaran N, Bookkamana P, Pinyopornpanish M, Saisavoey N, Wannarit K, Satthapisit S, Tanchakvaranont S
Neuropsychiatric Disease and Treatment 2016, 12:3175-3181
Published Date: 12 December 2016
Treadmill exercise promotes neuroprotection against cerebral ischemia–reperfusion injury via downregulation of pro-inflammatory mediators
Zhang Y, Cao RY, Jia X, Li Q, Qiao L, Yan G, Yang J
Neuropsychiatric Disease and Treatment 2016, 12:3161-3173
Published Date: 12 December 2016
Effect of dexmedetomidine on hippocampal neuron development and BDNF-TrkB signal expression in neonatal rats
Lv J, Ou W, Zou XH, Yao Y, Wu JL
Neuropsychiatric Disease and Treatment 2016, 12:3153-3159
Published Date: 9 December 2016
Baicalein improves behavioral dysfunction induced by Alzheimer’s disease in rats
Zhou L, Tan S, Shan YL, Wang YG, Cai W, Huang XH, Liao XY, Li HY, Zhang L, Zhang BJ, Lu ZQ
Neuropsychiatric Disease and Treatment 2016, 12:3145-3152
Published Date: 9 December 2016
Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis
He HR, Wu HH, Yang LH, Gao F, Fan YJ, Feng JQ, Ma XC
Neuropsychiatric Disease and Treatment 2016, 12:3129-3144
Published Date: 9 December 2016
Relationship between suicide rate and economic growth and stock market in the People’s Republic of China: 2004–2013
Yin HL, Xu L, Shao YC, Li LP, Wan CS
Neuropsychiatric Disease and Treatment 2016, 12:3119-3128
Published Date: 8 December 2016
Diminished autonomic neurocardiac function in patients with generalized anxiety disorder
Kim K, Lee S, Kim JH
Neuropsychiatric Disease and Treatment 2016, 12:3111-3118
Published Date: 8 December 2016
A randomized controlled trial of a mindfulness-based intervention program for people with schizophrenia: 6-month follow-up
Wang LQ, Chien WT, Yip LK, Karatzias T
Neuropsychiatric Disease and Treatment 2016, 12:3097-3110
Published Date: 7 December 2016
Age-related issues of instruments screening for autism in young children
Thomaidis L, Choleva A, Kyprianou M
Neuropsychiatric Disease and Treatment 2016, 12:3093-3095
Published Date: 5 December 2016
miR-455 inhibits neuronal cell death by targeting TRAF3 in cerebral ischemic stroke
Yao ST, Tang B, Li G, Fan RM, Cao F
Neuropsychiatric Disease and Treatment 2016, 12:3083-3092
Published Date: 5 December 2016
Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials
Durgam S, Chen C, Gommoll CP, Edwards J, Citrome L
Neuropsychiatric Disease and Treatment 2016, 12:3073-3081
Published Date: 2 December 2016
Global economic burden of schizophrenia: letter in response
Neil AL, Carr VJ
Neuropsychiatric Disease and Treatment 2016, 12:3069-3072
Published Date: 5 December 2016
Association between serotonin transporter gene polymorphisms and heroin dependence: a meta-analytic study
Lin PY, Wu YS
Neuropsychiatric Disease and Treatment 2016, 12:3061-3067
Published Date: 30 November 2016
A novel herbal treatment reduces depressive-like behaviors and increases brain-derived neurotrophic factor levels in the brain of type 2 diabetic rats
Luo C, Ke YT, Yuan YY, Zhao M, Wang FY, Zhang YS, Bu SH
Neuropsychiatric Disease and Treatment 2016, 12:3051-3059
Published Date: 29 November 2016
A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
Kishi T, Matsuda Y, Matsunaga S, Mukai T, Moriwaki M, Tabuse H, Fujita K, Iwata N
Neuropsychiatric Disease and Treatment 2016, 12:3041-3049
Published Date: 28 November 2016
Functional cortical changes in relapsing-remitting multiple sclerosis at amplitude configuration: a resting-state fMRI study
Liu H, Chen H, Wu B, Zhang TJ, Wang J, Huang KX, Song GJ, Zhan J
Neuropsychiatric Disease and Treatment 2016, 12:3031-3039
Published Date: 25 November 2016
Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders – a cross-sectional study
Holubova M, Prasko J, Matousek S, Latalova K, Marackova M, Vrbova K, Grambal A, Slepecky M, Zatkova M
Neuropsychiatric Disease and Treatment 2016, 12:3021-3030
Published Date: 24 November 2016
Self-stigma and schizophrenia: a cross-sectional study
Vrbova K, Prasko J, Holubova M, Kamaradova D, Ociskova M, Marackova M, Latalova K, Grambal A, Slepecky M, Zatkova M
Neuropsychiatric Disease and Treatment 2016, 12:3011-3020
Published Date: 24 November 2016
Factors related to depression and anxiety in adults with bronchiectasis
Özgün Niksarlioglu EY, Özkan G, Günlüoglu G, Uysal MA, Gül S, Kilic L, Yeter A, Çamsari G
Neuropsychiatric Disease and Treatment 2016, 12:3005-3010
Published Date: 23 November 2016
Evaluation of novel candidate variations and their interactions related to bipolar disorders: Analysis of GWAS data
Acikel C, Aydin Son Y, Celik C, Gul H
Neuropsychiatric Disease and Treatment 2016, 12:2997-3004
Published Date: 24 November 2016
Prevalence of alcohol use disorders and associated factors among people with epilepsy attending Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia
Waja T, Ebrahim J, Yohannis Z, Bedaso A
Neuropsychiatric Disease and Treatment 2016, 12:2989-2996
Published Date: 22 November 2016
Perceptions and impact of bipolar disorder in Japan: results of an Internet survey
Watanabe K, Harada E, Inoue T, Tanji Y, Kikuchi T
Neuropsychiatric Disease and Treatment 2016, 12:2981-2987
Published Date: 21 November 2016
Factors associated with vitamin D status of low-income, hospitalized psychiatric patients: results of a retrospective study
Bazzano AN, Littrell L, Lambert S, Roi C
Neuropsychiatric Disease and Treatment 2016, 12:2973-2980
Published Date: 15 November 2016
ADHD and Present Hedonism: time perspective as a potential diagnostic and therapeutic tool
Weissenberger S, Klicperova-Baker M, Zimbardo P, Schonova K, Akotia D, Kostal J, Goetz M, Raboch J, Ptacek R
Neuropsychiatric Disease and Treatment 2016, 12:2963-2971
Published Date: 16 November 2016
The occurrence and predictive factors of sleep paralysis in university students
Lišková M, Janečková D, Klůzová Kráčmarová L, Mladá K, Bušková J
Neuropsychiatric Disease and Treatment 2016, 12:2957-2962
Published Date: 14 November 2016
Altered spontaneous brain activity pattern in patients with high myopia using amplitude of low-frequency fluctuation: a resting-state fMRI study
Huang X, Zhou FQ, Hu YX, Xu XX, Zhou X, Zhong YL, Wang J, Wu XR
Neuropsychiatric Disease and Treatment 2016, 12:2949-2956
Published Date: 14 November 2016
Posttraumatic stress and depression in Yazidi refugees
Nasıroğlu S, Çeri V
Neuropsychiatric Disease and Treatment 2016, 12:2941-2948
Published Date: 14 November 2016
Sex differences in the course of schizophrenia across diverse regions of the world
Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM
Neuropsychiatric Disease and Treatment 2016, 12:2927-2939
Published Date: 14 November 2016
Assessment of suicidality in children and adolescents with diagnosis of high functioning autism spectrum disorder in a Turkish clinical sample
Karakoç Demirkaya S, Tutkunkardaş MD, Mukaddes NM
Neuropsychiatric Disease and Treatment 2016, 12:2921-2926
Published Date: 11 November 2016
Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease
Rej S, Saleem M, Herrmann N, Stefatos A, Rau A, Lanctôt KL
Neuropsychiatric Disease and Treatment 2016, 12:2913-2920
Published Date: 10 November 2016
Increased miR-132 level is associated with visual memory dysfunction in patients with depression
Liu Y, Yang X, Zhao L, Zhang J, Li T, Ma X
Neuropsychiatric Disease and Treatment 2016, 12:2905-2911
Published Date: 9 November 2016
Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis
Blay SL, Aguiar JV, Passos IC
Neuropsychiatric Disease and Treatment 2016, 12:2895-2903
Published Date: 8 November 2016
Post-stroke dyskinesias
Nakawah MO, Lai EC
Neuropsychiatric Disease and Treatment 2016, 12:2885-2893
Published Date: 7 November 2016
The NCAN gene: schizophrenia susceptibility and cognitive dysfunction
Wang P, Cai J, Ni J, Zhang J, Tang W, Zhang C
Neuropsychiatric Disease and Treatment 2016, 12:2875-2883
Published Date: 4 November 2016
The reduction of CSF tumor necrosis factor alpha levels in schizophrenia: no correlations with psychopathology and coincident metabolic characteristics
Zhu H, Wang D, Liu X
Neuropsychiatric Disease and Treatment 2016, 12:2869-2874
Published Date: 3 November 2016
Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies
Han Y, Chen J, Zou D, Zheng P, Li Q, Wang H, Li P, Zhou X, Zhang Y, Liu Y, Xie P
Neuropsychiatric Disease and Treatment 2016, 12:2859-2867
Published Date: 3 November 2016
A modification of intraluminal middle cerebral artery occlusion/reperfusion model for ischemic stroke with laser Doppler flowmetry guidance in mice
Cai Q, Xu G, Liu J, Wang L, Deng G, Liu J, Chen Z
Neuropsychiatric Disease and Treatment 2016, 12:2851-2858
Published Date: 3 November 2016
Effects of multiple training modalities in patients with Alzheimer’s disease: a pilot study
Tai SY, Hsu CL, Huang SW, Ma TC, Hsieh WC, Yang YH
Neuropsychiatric Disease and Treatment 2016, 12:2843-2849
Published Date: 1 November 2016
Vertebral artery dissection with compelling evidence on duplex ultrasound presenting only with neck pain
Siepmann T, Borchert M, Barlinn K
Neuropsychiatric Disease and Treatment 2016, 12:2839-2841
Published Date: 1 November 2016
Effect of Yi-nao-jie-yu decoction on γ-aminobutyric acid type A receptor in the hippocampus and serum inflammatory factors in a rat model of poststroke anxiety
Zhang W, Zhao R, Li X, Cui X, Zhao Z, Mao Y, Wu F, Tang Q
Neuropsychiatric Disease and Treatment 2016, 12:2827-2837
Published Date: 1 November 2016
Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia
Wang LJ, Lin PY, Lee Y, Huang YC, Hsu ST, Hung CF, Chen CK, Chen YC, Wang YL, Tsai MC
Neuropsychiatric Disease and Treatment 2016, 12:2819-2826
Published Date: 31 October 2016
Beliefs and perception about mental health issues: a meta-synthesis
Choudhry FR, Mani V, Ming LC, Khan TM
Neuropsychiatric Disease and Treatment 2016, 12:2807-2818
Published Date: 31 October 2016
Psychometric properties of the self-rating organization scale with adult samples
Takeda T, Tsuji Y, Ando M
Neuropsychiatric Disease and Treatment 2016, 12:2799-2806
Published Date: 31 October 2016
Effect of low-energy extracorporeal shock wave on vascular regeneration after spinal cord injury and the recovery of motor function [Retraction]
Wang L, Jiang YQ, Jiang Z, Han LZ
Neuropsychiatric Disease and Treatment 2016, 12:2797-2798
Published Date: 31 October 2016
Production of inflammatory cytokines, cortisol, and Aβ1-40 in elderly oral cancer patients with postoperative delirium
Sun L, Jia P, Zhang J, Zhang X, Zhang Y, Jiang H, Jiang W, Guo Y
Neuropsychiatric Disease and Treatment 2016, 12:2789-2795
Published Date: 27 October 2016
Autoimmune encephalitis in psychiatric institutions: current perspectives
Bost C, Pascual O, Honnorat J
Neuropsychiatric Disease and Treatment 2016, 12:2775-2787
Published Date: 27 October 2016
Prevalence and related factors of psychological distress among cancer inpatients using routine Distress Thermometer and Chinese Health Questionnaire screening
Chiou YJ, Chiu NM, Wang LJ, Li SH, Lee CY, Wu MK, Chen CC, Wu YS, Lee Y
Neuropsychiatric Disease and Treatment 2016, 12:2765-2773
Published Date: 25 October 2016
Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
Solem CT, Shelbaya A, Wan Y, Deshpande CG, Alvir J, Pappadopulos E
Neuropsychiatric Disease and Treatment 2016, 12:2755-2764
Published Date: 25 October 2016
A pilot study of cognitive training with and without transcranial direct current stimulation to improve cognition in older persons with HIV-related cognitive impairment
Ownby RL, Acevedo A
Neuropsychiatric Disease and Treatment 2016, 12:2745-2754
Published Date: 25 October 2016
Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being
Anand E, Berggren L, Landry J, Tóth Á, Detke HC
Neuropsychiatric Disease and Treatment 2016, 12:2737-2743
Published Date: 25 October 2016
Alpha-synuclein in cutaneous small nerve fibers
Siepmann T, Illigens BM, Barlinn K
Neuropsychiatric Disease and Treatment 2016, 12:2731-2735
Published Date: 25 October 2016
Prevalence of unrecognized depression and associated factors among patients attending medical outpatient department in Adare Hospital, Hawassa, Ethiopia
Tilahune AB, Bekele G, Mekonnen N, Tamiru E
Neuropsychiatric Disease and Treatment 2016, 12:2723-2729
Published Date: 25 October 2016
Exercise is medicine for depression: even when the “pill” is small
Hallgren M, Vancampfort D, Stubbs B
Neuropsychiatric Disease and Treatment 2016, 12:2715-2721
Published Date: 25 October 2016
Efficacy and safety of multiple doses of levomilnacipran extended-release for the treatment of major depressive disorder
Huang Q, Zhong X, Yun Y, Yu B, Huang Y
Neuropsychiatric Disease and Treatment 2016, 12:2707-2714
Published Date: 25 October 2016
Hyperbaric oxygen therapy as a potential treatment for post-traumatic stress disorder associated with traumatic brain injury
Eve DJ, Steele MR, Sanberg PR, Borlongan CV
Neuropsychiatric Disease and Treatment 2016, 12:2689-2705
Published Date: 20 October 2016
Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study
Holubova M, Prasko J, Ociskova M, Marackova M, Grambal A, Slepecky M
Neuropsychiatric Disease and Treatment 2016, 12:2677-2687
Published Date: 19 October 2016
Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders
Prasko J, Grambal A, Kasalova P, Kamaradova D, Ociskova M, Holubova M, Vrbova K, Sigmundova Z, Latalova K, Slepecky M, Zatkova M
Neuropsychiatric Disease and Treatment 2016, 12:2659-2676
Published Date: 17 October 2016
Use of the Hospital Anxiety and Depression Scale and the Taiwanese Depression Questionnaire for screening depression in head and neck cancer patients in Taiwan
Lee Y, Wu YS, Chien CY, Fang FM, Hung CF
Neuropsychiatric Disease and Treatment 2016, 12:2649-2657
Published Date: 13 October 2016
Changes in behavior as side effects in methylphenidate treatment: review of the literature
Konrad-Bindl DS, Gresser U, Richartz BM
Neuropsychiatric Disease and Treatment 2016, 12:2635-2647
Published Date: 12 October 2016
Shortened questionnaires to assess anxiety and depression during in-hospital rehabilitation: clinical validation and cutoff scores
Bertolotti G, Moroni L, Burro R, Spanevello A, Pedretti RFE, Giorgetti G
Neuropsychiatric Disease and Treatment 2016, 12:2627-2633
Published Date: 12 October 2016
Physical activity and self-esteem: testing direct and indirect relationships associated with psychological and physical mechanisms
Zamani Sani SH, Fathirezaie Z, Brand S, Pühse U, Holsboer-Trachsler E, Gerber M, Talepasand S
Neuropsychiatric Disease and Treatment 2016, 12:2617-2625
Published Date: 12 October 2016
Managing drug-resistant epilepsy: challenges and solutions
Dalic L, Cook MJ
Neuropsychiatric Disease and Treatment 2016, 12:2605-2616
Published Date: 12 October 2016
Impact of aggression, depression, and anxiety levels on quality of life in epilepsy patients
Izci F, Fındıklı E, Camkurt MA, Tuncel D, Şahin M
Neuropsychiatric Disease and Treatment 2016, 12:2595-2603
Published Date: 13 October 2016
Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole
Peters-Strickland T, Pestreich L, Hatch A, Rohatagi S, Baker RA, Docherty JP, Markovtsova L, Raja P, Weiden PJ, Walling DP
Neuropsychiatric Disease and Treatment 2016, 12:2587-2594
Published Date: 11 October 2016
Restless leg syndrome in hospitalized psychiatric patients in Lebanon: a pilot study
Talih F, Ajaltouni J, Kobeissy F
Neuropsychiatric Disease and Treatment 2016, 12:2581-2586
Published Date: 11 October 2016
Evaluation of anxiety condition among type 1 and type 2 diabetic patients
Bulut A, Bulut A
Neuropsychiatric Disease and Treatment 2016, 12:2573-2579
Published Date: 11 October 2016
Vagus nerve stimulation balanced disrupted default-mode network and salience network in a postsurgical epileptic patient
Wang KL, Chai Q, Qiao H, Zhang JG, Liu TH, Meng FG
Neuropsychiatric Disease and Treatment 2016, 12:2561-2571
Published Date: 11 October 2016
Screening results correlating to personality disorder traits in a new employee population of People's Republic of China
Tan Y, Liu Y, Wu L
Neuropsychiatric Disease and Treatment 2016, 12:2553-2560
Published Date: 6 October 2016
Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder
Prasko J, Ociskova M, Grambal A, Sigmundova Z, Kasalova P, Marackova M, Holubova M, Vrbova K, Latalova K, Slepecky M
Neuropsychiatric Disease and Treatment 2016, 12:2539-2552
Published Date: 7 October 2016
Identifying predictive clinical characteristics of the treatment efficacy of mirtazapine monotherapy for major depressive disorder
Tsutsumi T, Sugawara H, Ito R, Asano M, Shimizu S, Ishigooka J, Nishimura K
Neuropsychiatric Disease and Treatment 2016, 12:2533-2538
Published Date: 5 October 2016
Impaired social cognition in anorexia nervosa patients
Hamatani S, Tomotake M, Takeda T, Kameoka N, Kawabata M, Kubo H, Tada Y, Tomioka Y, Watanabe S, Ohmori T
Neuropsychiatric Disease and Treatment 2016, 12:2527-2531
Published Date: 5 October 2016
Screening for attention deficit and hyperactivity disorder, autism spectrum disorder, and developmental delay in Taiwanese aboriginal preschool children
Chan HL, Liu WS, Hsieh YH, Lin CF, Ling TS, Huang YS
Neuropsychiatric Disease and Treatment 2016, 12:2521-2526
Published Date: 4 October 2016
Role of berberine in Alzheimer’s disease
Cai Z, Wang C, Yang W
Neuropsychiatric Disease and Treatment 2016, 12:2509-2520
Published Date: 3 October 2016
Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
Tomita T, Yasui-Furukori N, Sugawara N, Ogasawara K, Katagai K, Saito H, Sawada K, Takahashi I, Nakamura K
Neuropsychiatric Disease and Treatment 2016, 12:2503-2508
Published Date: 30 September 2016
Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
Schettino C, Dato C, Capaldo G, Sampaolo S, Di Iorio G, Melone MA
Neuropsychiatric Disease and Treatment 2016, 12:2497-2502
Published Date: 29 September 2016
Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer’s disease
Li W, Wang T, Xiao S
Neuropsychiatric Disease and Treatment 2016, 12:2489-2495
Published Date: 29 September 2016
Traditional Chinese medicine Yisui Tongjing relieved neural severity in experimental autoimmune neuritis rat model
Zhang E, Li M, Zhao J, Dong Y, Yang X, Huang J
Neuropsychiatric Disease and Treatment 2016, 12:2481-2487
Published Date: 29 September 2016
Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel?
Hendaus MA, Jomha FA, Alhammadi AH
Neuropsychiatric Disease and Treatment 2016, 12:2473-2479
Published Date: 27 September 2016
A longitudinal, event-related potential pilot study of adult obsessive-compulsive disorder with 1-year follow-up
Yamamuro K, Okada K, Kishimoto N, Ota T, Iida J, Kishimoto T
Neuropsychiatric Disease and Treatment 2016, 12:2463-2471
Published Date: 26 September 2016
An online survey of Turkish psychiatrists’ attitudes about and experiences of adult attention deficit hyperactivity disorder in clinical practice
Altın M, Altın GE, Semerci B
Neuropsychiatric Disease and Treatment 2016, 12:2455-2461
Published Date: 4 October 2016
Development of psychotic symptoms following ingestion of small quantities of alcohol
Lu DL, Lin XL
Neuropsychiatric Disease and Treatment 2016, 12:2449-2454
Published Date: 22 September 2016
Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders
Grambal A, Prasko J, Kamaradova D, Latalova K, Holubova M, Marackova M, Ociskova M, Slepecky M
Neuropsychiatric Disease and Treatment 2016, 12:2439-2448
Published Date: 22 September 2016
Mean platelet volume and red cell distribution width levels in initial evaluation of panic disorder
Asoglu M, Aslan M, Imre O, Kivrak Y, Akil O, Savik E, Buyukaslan H, Fedai U, Altındag A
Neuropsychiatric Disease and Treatment 2016, 12:2435-2438
Published Date: 22 September 2016
Delirium as a complication of the surgical intensive care
Horacek R, Krnacova B, Prasko J, Latalova K
Neuropsychiatric Disease and Treatment 2016, 12:2425-2434
Published Date: 22 September 2016
Increased frontal electroencephalogram theta amplitude in patients with anorexia nervosa compared to healthy controls
Hestad KA, Weider S, Nilsen KB, Indredavik MS, Sand T
Neuropsychiatric Disease and Treatment 2016, 12:2419-2423
Published Date: 21 September 2016
miR-370 mimic inhibits replication of Japanese encephalitis virus in glioblastoma cells
Li W, Cheng P, Nie S, Cui W
Neuropsychiatric Disease and Treatment 2016, 12:2411-2417
Published Date: 21 September 2016
Distinctive Rorschach profiles of young adults with schizophrenia and autism spectrum disorder
Kishimoto N, Yamamuro K, Iida J, Ota T, Tanaka S, Kyo M, Kimoto S, Kishimoto T
Neuropsychiatric Disease and Treatment 2016, 12:2403-2410
Published Date: 21 September 2016
Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review
Feng DD, Tang T, Lin XP, Yang ZY, Yang S, Xia ZA, Wang Y, Zheng P, Wang Y, Zhang CH
Neuropsychiatric Disease and Treatment 2016, 12:2387-2402
Published Date: 20 September 2016
Varenicline improves motor and cognitive symptoms in early Huntington’s disease
McGregor AL, Dysart J, Tingle MD, Russell BR, Kydd RR, Finucane G
Neuropsychiatric Disease and Treatment 2016, 12:2381-2386
Published Date: 19 September 2016
Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode
Kurita M
Neuropsychiatric Disease and Treatment 2016, 12:2373-2380
Published Date: 20 September 2016
Expanded DMPK repeats in dizygotic twins referred for diagnosis of autism versus absence of expanded DMPK repeats at screening of 330 children with autism
Musova Z, Hancarova M, Havlovicova M, Pourova R, Hrdlicka M, Kraus J, Trkova M, Stejskal D, Sedlacek Z
Neuropsychiatric Disease and Treatment 2016, 12:2367-2372
Published Date: 19 September 2016
Epilepsia partialis continua present with shoulder joint-trunk-hip joint rhythmic clonic seizure: a case report
Lv YD, Wang Z, Chu FN, Liu C, Meng H
Neuropsychiatric Disease and Treatment 2016, 12:2363-2366
Published Date: 19 September 2016
The role of augmentative and alternative communication for children with autism: current status and future trends
Iacono T, Trembath D, Erickson S
Neuropsychiatric Disease and Treatment 2016, 12:2349-2361
Published Date: 20 September 2016
Splitting, impulsivity, and intimate partnerships in young obese women seeking bariatric treatment
Zmolikova J, Pichlerova D, Bob P, Schückova D, Herlesova J, Weiss P
Neuropsychiatric Disease and Treatment 2016, 12:2343-2347
Published Date: 16 September 2016
Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction
Tian XQ, Wang Q, Guo R, Xu LL, Chen QM, Hou YL
Neuropsychiatric Disease and Treatment 2016, 12:2333-2341
Published Date: 13 September 2016
The role of NMDAR antibody in the etiopathogenesis of schizophrenia
Timucin D, Ozdemir O, Parlak M
Neuropsychiatric Disease and Treatment 2016, 12:2327-2332
Published Date: 13 September 2016
Autistic traits in women with primary dysmenorrhea: a case–control study
Toy H, Hergüner A, Şimşek S, Hergüner S
Neuropsychiatric Disease and Treatment 2016, 12:2319-2325
Published Date: 12 September 2016
Alexithymia, impulsiveness, and psychopathology in nonsuicidal self-injured adolescents
Gatta M, Dal Santo F, Rago A, Spoto A, Battistella PA
Neuropsychiatric Disease and Treatment 2016, 12:2307-2317
Published Date: 12 September 2016
Prescription patterns of benzodiazepines in the Lebanese adult population: a cross-sectional study
Ramadan WH, El Khoury GM, Deeb ME, Sheikh-Taha M
Neuropsychiatric Disease and Treatment 2016, 12:2299-2305
Published Date: 6 September 2016
Insomnia in patients on hemodialysis for a short versus long duration
Tomita T, Yasui-Furukori N, Oka M, Shimizu T, Nagashima A, Mitsuhashi K, Saito H, Nakamura K
Neuropsychiatric Disease and Treatment 2016, 12:2293-2298
Published Date: 2 September 2016
The combined effect of sleep and time of day on emotion decoding from dynamic visual cues in older adults
Tsokanaki P, Moraitou D, Papantoniou G
Neuropsychiatric Disease and Treatment 2016, 12:2283-2291
Published Date: 1 September 2016
Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report
Igata R, Hori H, Atake K, Katsuki A, Nakamura J
Neuropsychiatric Disease and Treatment 2016, 12:2279-2281
Published Date: 1 September 2016
The positive effects of high-frequency right dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation on memory, correlated with increases in brain metabolites detected by proton magnetic resonance spectroscopy in recently detoxified alcohol-dependent patients
Qiao J, Jin G, Lei L, Wang L, Du Y, Wang X
Neuropsychiatric Disease and Treatment 2016, 12:2273-2278
Published Date: 13 September 2016
Suicidality and symptoms of anxiety, irritability, and agitation in patients experiencing manic episodes with depressive symptoms: a naturalistic study
Eberhard J, Weiller E
Neuropsychiatric Disease and Treatment 2016, 12:2265-2271
Published Date: 31 August 2016
Children who screen positive for autism at 2.5 years and receive early intervention: a prospective naturalistic 2-year outcome study
Spjut Jansson B, Miniscalco C, Westerlund J, Kantzer AK, Fernell E, Gillberg C
Neuropsychiatric Disease and Treatment 2016, 12:2255-2263
Published Date: 1 September 2016
Construction of standardized Arabic questionnaires for screening neurological disorders (dementia, stroke, epilepsy, movement disorders, muscle and neuromuscular junction disorders)
El Tallawy HN, Farghaly WMA, Rageh TA, Saleh AO, Mestekawy TAH, Darwish MMM, Abd El Hamed MA, Ali AM, Mahmoud DM
Neuropsychiatric Disease and Treatment 2016, 12:2245-2253
Published Date: 30 August 2016
Psychological distress and coping in military cadre candidates
Nakkas C, Annen H, Brand S
Neuropsychiatric Disease and Treatment 2016, 12:2237-2243
Published Date: 29 August 2016
Investigation on Internet addiction disorder in adolescents in Anhui, People’s Republic of China
Chen Y, Kang Y, Gong W, He L, Jin Y, Zhu X, Yao Y
Neuropsychiatric Disease and Treatment 2016, 12:2233-2236
Published Date: 29 August 2016
Association between sequence variations of the Mediterranean fever gene and the risk of migraine: a case–control study
Coşkun S, Varol S, Özdemir HH, Çelik SB, Balduz M, Camkurt MA, Çim A, Arslan D, Çevik MU
Neuropsychiatric Disease and Treatment 2016, 12:2225-2232
Published Date: 29 August 2016
Characteristics of binge eating disorder in relation to diagnostic criteria
Wilfley DE, Citrome L, Herman BK
Neuropsychiatric Disease and Treatment 2016, 12:2213-2223
Published Date: 29 August 2016
Late life bipolar disorder evolving into frontotemporal dementia mimic
Dols A, Krudop W, Möller C, Shulman K, Sajatovic M, Pijnenburg YAL
Neuropsychiatric Disease and Treatment 2016, 12:2207-2212
Published Date: 7 September 2016
Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer’s Disease Neuroimaging Initiative
Russo MJ, Cohen G, Chrem Mendez P, Campos J, Nahas FE, Surace EI, Vazquez S, Gustafson D, Guinjoan S, Allegri RF, Sevlever G
Neuropsychiatric Disease and Treatment 2016, 12:2199-2206
Published Date: 13 September 2016
Effect of low-energy extracorporeal shock wave on vascular regeneration after spinal cord injury and the recovery of motor function
Wang L, Jiang YQ, Jiang Z, Han LZ
Neuropsychiatric Disease and Treatment 2016, 12:2189-2198
Published Date: 31 August 2016
Diffusion tensor imaging in the characterization of multiple system atrophy
Rulseh AM, Keller J, Rusz J, Syka M, Brozova H, Rusina R, Havrankova P, Zarubova K, Malikova H, Jech R, Vymazal J
Neuropsychiatric Disease and Treatment 2016, 12:2181-2187
Published Date: 26 August 2016
Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults
Nakato Y, Inoue T, Nakagawa S, Kitaichi Y, Kameyama R, Wakatsuki Y, Kitagawa K, Omiya Y, Kusumi I
Neuropsychiatric Disease and Treatment 2016, 12:2173-2179
Published Date: 25 August 2016
Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
Capal JK, Franz DN
Neuropsychiatric Disease and Treatment 2016, 12:2165-2172
Published Date: 25 August 2016
Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse
Sternat T, Katzman MA
Neuropsychiatric Disease and Treatment 2016, 12:2149-2164
Published Date: 25 August 2016
Olfactory functioning in early multiple sclerosis: Sniffin’ Sticks Test study
Batur Caglayan HZ, Irkec C, Nazliel B, Akyol Gurses A, Capraz I
Neuropsychiatric Disease and Treatment 2016, 12:2143-2147
Published Date: 26 August 2016
The use of the Psychiatric Electroencephalography Evaluation Registry (PEER) to personalize pharmacotherapy
Iosifescu DV, Neborsky RJ, Valuck RJ
Neuropsychiatric Disease and Treatment 2016, 12:2131-2142
Published Date: 25 August 2016
Brain tissue partial pressure of oxygen predicts the outcome of severe traumatic brain injury under mild hypothermia treatment
Sun H, Zheng M, Wang Y, Diao Y, Zhao W, Wei Z
Neuropsychiatric Disease and Treatment 2016, 12:2125-2129
Published Date: 24 August 2016
Disruptive mood dysregulation disorder: current insights
Baweja R, Mayes SD, Hameed U, Waxmonsky JG
Neuropsychiatric Disease and Treatment 2016, 12:2115-2124
Published Date: 24 August 2016
Mood disorders in the elderly: prevalence, functional impact, and management challenges
Valiengo LCL, Stella F, Forlenza OV
Neuropsychiatric Disease and Treatment 2016, 12:2105-2114
Published Date: 24 August 2016
Improvement in social and cognitive functioning associated with paliperidone extended-release treatment in patients with schizophrenia: a 24-week, single arm, open-label study
Shi C, Yao SQ, Xu YF, Shi JG, Xu XF, Zhang CP, Jin H, Yu X
Neuropsychiatric Disease and Treatment 2016, 12:2095-2104
Published Date: 24 August 2016
Aberrant brain-stem morphometry associated with sleep disturbance in drug-naïve subjects with Alzheimer's disease
Lee JH, Jung WS, Choi WH, Lim HK
Neuropsychiatric Disease and Treatment 2016, 12:2089-2093
Published Date: 23 August 2016
Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study
Wang G, Cheng Y, Wang JN, Wu SH, Xue HB
Neuropsychiatric Disease and Treatment 2016, 12:2077-2087
Published Date: 22 August 2016
Forensic reporting of a case of sexual abuse broadcast on periscope
Nasıroğlu S, Çimen İD
Neuropsychiatric Disease and Treatment 2016, 12:2073-2075
Published Date: 19 August 2016
Mental health care use in medically unexplained and explained physical symptoms: findings from a general population study
van Eck van der Sluijs JF, ten Have M, Rijnders CA, van Marwijk HWJ, de Graaf R, van der Feltz-Cornelis CM
Neuropsychiatric Disease and Treatment 2016, 12:2063-2072
Published Date: 16 August 2016
Mean platelet volume in bipolar disorder: the search for an ideal biomarker
Mert DG, Terzi H
Neuropsychiatric Disease and Treatment 2016, 12:2057-2062
Published Date: 16 August 2016
The interactive effects of ketamine and magnesium upon depressive-like pathology
Razmjou S, Litteljohn D, Rudyk C, Syed S, Clarke M, Pentz R, Dwyer Z, Hayley S
Neuropsychiatric Disease and Treatment 2016, 12:2049-2056
Published Date: 8 September 2016
Evaluation and follow-up of cognitive functions in patients with minor stroke and transient ischemic attack
Deniz Ç, Çelik Y, Özdemir Gültekin T, Baran GE, Deniz Ç, Asil T
Neuropsychiatric Disease and Treatment 2016, 12:2039-2048
Published Date: 16 August 2016
Higher minor hemoglobin A2 levels in multiple sclerosis patients correlate with lesser disease severity
Ozcan ME, Ince B, Karadeli HH, Gedikbasi A, Asil T, Altinoz MA
Neuropsychiatric Disease and Treatment 2016, 12:2033-2038
Published Date: 16 August 2016
Is cobalamin deficiency associated with increased risk for all subtypes of postoperative delirium?
Wang LK, Lan KM, Lin YT, Chen JY
Neuropsychiatric Disease and Treatment 2016, 12:2029-2031
Published Date: 16 August 2016
HIV- and AIDS-associated neurocognitive functioning in Zambia – a perspective based on differences between the genders
Kabuba N, Menon JA, Franklin Jr DR, Heaton RK, Hestad KA
Neuropsychiatric Disease and Treatment 2016, 12:2021-2028
Published Date: 11 August 2016
Altered spontaneous brain activity patterns in patients with unilateral acute open globe injury using amplitude of low-frequency fluctuation: a functional magnetic resonance imaging study
Tan G, Huang X, Ye L, Wu AH, He LX, Zhong YL, Jiang N, Zhou FQ, Shao Y
Neuropsychiatric Disease and Treatment 2016, 12:2015-2020
Published Date: 11 August 2016
Microstructural changes of whole brain in patients with comitant strabismus: evidence from a diffusion tensor imaging study
Huang X, Li HJ, Zhang Y, Peng DC, Hu PH, Zhong YL, Zhou FQ, Shao Y
Neuropsychiatric Disease and Treatment 2016, 12:2007-2014
Published Date: 12 August 2016
Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia
Kulaksizoglu B, Kulaksizoglu S
Neuropsychiatric Disease and Treatment 2016, 12:1999-2005
Published Date: 12 August 2016
Association of depression with sleep quality might be greater than that of pain intensity among outpatients with chronic low back pain
Wang HY, Fu TS, Hsu SC, Hung CI
Neuropsychiatric Disease and Treatment 2016, 12:1993-1998
Published Date: 9 August 2016
Two-year prognosis after residential treatment for patients with alcohol dependence: three chief guidelines for sobriety in Japan
Cho T, Negoro H, Saka Y, Morikawa M, Kishimoto T
Neuropsychiatric Disease and Treatment 2016, 12:1983-1991
Published Date: 5 August 2016
Exercise is medicine for patients with major depressive disorders : but only if the “pill” is taken!
Gerber M, Holsboer-Trachsler E, Pühse U, Brand S
Neuropsychiatric Disease and Treatment 2016, 12:1977-1981
Published Date: 5 August 2016
Brief behavioral treatment for patients with treatment-resistant insomnia
Wang J, Wei Q, Wu X, Zhong Z, Li G
Neuropsychiatric Disease and Treatment 2016, 12:1967-1975
Published Date: 4 August 2016
The effect of cross-sex hormonal treatment on gender dysphoria individuals' mental health: a systematic review
Costa R, Colizzi M
Neuropsychiatric Disease and Treatment 2016, 12:1953-1966
Published Date: 4 August 2016
Stress, anxiety, and depression among parents of children with autism spectrum disorder in Oman: a case–control study
Al-Farsi OA, Al-Farsi YM, Al-Sharbati MM, Al-Adawi S
Neuropsychiatric Disease and Treatment 2016, 12:1943-1951
Published Date: 4 August 2016
Effects of escitalopram with a Chinese traditional compound Jiuweizhenxin-keli on mismatch negativity and P50 in patients with major depressive disorders
Kuang W, Tian L, Yue L, Li J
Neuropsychiatric Disease and Treatment 2016, 12:1935-1941
Published Date: 3 August 2016
Cycloid psychoses in the psychosis spectrum: evidence for biochemical differences with schizophrenia
van de Kerkhof NW, Fekkes D, van der Heijden FM, Hoogendijk WJ, Stöber G, Egger JI, Verhoeven WM
Neuropsychiatric Disease and Treatment 2016, 12:1927-1933
Published Date: 2 August 2016
Discriminating poststroke depression from stroke by nuclear magnetic resonance spectroscopy-based metabonomic analysis
Xiao J, Zhang J, Sun D, Wang L, Yu L, Wu H, Wang D, Qiu X
Neuropsychiatric Disease and Treatment 2016, 12:1919-1925
Published Date: 2 August 2016
Pain perception: predictive value of sex, depression, anxiety, somatosensory amplification, obesity, and age
Kivrak Y, Kose-Ozlece H, Ustundag MF, Asoglu M
Neuropsychiatric Disease and Treatment 2016, 12:1913-1918
Published Date: 1 August 2016
A study of patients with aggressive multiple sclerosis at disease onset
Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS
Neuropsychiatric Disease and Treatment 2016, 12:1907-1912
Published Date: 1 August 2016
Altered regional homogeneity in patients with unilateral acute open globe injury: a resting-state functional MRI study
Huang X, Li HJ, Ye L, Zhang Y, Wei R, Zhong YL, Peng DC, Shao Y
Neuropsychiatric Disease and Treatment 2016, 12:1901-1906
Published Date: 1 August 2016
Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients
Altintas M, Inanc L, Oruc GA, Arpacioglu S, Gulec H
Neuropsychiatric Disease and Treatment 2016, 12:1893-1900
Published Date: 2 August 2016
Clinical characteristics of patients with benign nonlesional temporal lobe epilepsy
Kim J, Kim SH, Lim SC, Kim W, Shon YM
Neuropsychiatric Disease and Treatment 2016, 12:1887-1891
Published Date: 28 July 2016
Post-stroke emotional incontinence or bipolar disorder?
Mnif L, Sellami R, Masmoudi J
Neuropsychiatric Disease and Treatment 2016, 12:1883-1885
Published Date: 29 July 2016
Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment
Königs A, Kiliaan AJ
Neuropsychiatric Disease and Treatment 2016, 12:1869-1882
Published Date: 26 July 2016
Borderline, avoidant, sadistic personality traits and emotion dysregulation predict different pathological skin picking subtypes in a community sample
Pozza A, Giaquinta N, Dèttore D
Neuropsychiatric Disease and Treatment 2016, 12:1861-1867
Published Date: 1 August 2016
Depression and pain: testing of serial multiple mediators
Wongpakaran T, Wongpakaran N, Tanchakvaranont S, Bookkamana P, Pinyopornpanish M, Wannarit K, Satthapisit S, Nakawiro D, Hiranyatheb T, Thongpibul K
Neuropsychiatric Disease and Treatment 2016, 12:1849-1860
Published Date: 25 July 2016
Association between obesity and the brain-derived neurotrophic factor gene polymorphism Val66Met in individuals with bipolar disorder in Mexican population
Morales-Marín ME, Genis-Mendoza AD, Tovilla-Zarate CA, Lanzagorta N, Escamilla M, Nicolini H
Neuropsychiatric Disease and Treatment 2016, 12:1843-1848
Published Date: 25 July 2016
Update on schizophrenia and bipolar disorder: focus on cariprazine
Roberts RJ, Findlay LJ, El-Mallakh PL, El-Mallakh RS
Neuropsychiatric Disease and Treatment 2016, 12:1837-1842
Published Date: 25 July 2016
Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials
Fornaro M, Solmi M, Perna G, De Berardis D, Veronese N, Orsolini L, Ganança L, Stubbs B
Neuropsychiatric Disease and Treatment 2016, 12:1827-1836
Published Date: 25 July 2016
Long-term administration of escitalopram in patients with social anxiety disorder in Japan
Asakura S, Hayano T, Hagino A, Koyama T
Neuropsychiatric Disease and Treatment 2016, 12:1817-1825
Published Date: 22 July 2016
Subgrouping of risky behaviors among Iranian college students: a latent class analysis
Safiri S, Rahimi-Movaghar A, Yunesian M, Sadeghi-Bazargani H, Shamsipour M, Mansournia MA, Fotouhi A
Neuropsychiatric Disease and Treatment 2016, 12:1809-1816
Published Date: 22 July 2016
Current and emerging treatment strategies for Duchenne muscular dystrophy
Mah JK
Neuropsychiatric Disease and Treatment 2016, 12:1795-1807
Published Date: 22 July 2016
The major risk factors for delirium in a clinical setting
Kim H, Chung S, Joo YH, Lee JS
Neuropsychiatric Disease and Treatment 2016, 12:1787-1793
Published Date: 21 July 2016
Association of brain-derived neurotrophic factor and nerve growth factor gene polymorphisms with susceptibility to migraine
Coskun S, Varol S, Ozdemir HH, Agacayak E, Aydın B, Kapan O, Camkurt MA, Tunc S, Cevik MU
Neuropsychiatric Disease and Treatment 2016, 12:1779-1785
Published Date: 19 July 2016
Parenting, identity development, internalizing symptoms, and alcohol use: a cross-sectional study in a group of Italian adolescents
Pellerone M, Tolini G, Polopoli C
Neuropsychiatric Disease and Treatment 2016, 12:1769-1778
Published Date: 18 July 2016
A clinician’s guide to recurrent isolated sleep paralysis
Sharpless BA
Neuropsychiatric Disease and Treatment 2016, 12:1761-1767
Published Date: 19 July 2016
Zika virus challenges for neuropsychiatry
Simões e Silva AC, Moreira JM, Romanelli RMC, Teixeira AL
Neuropsychiatric Disease and Treatment 2016, 12:1747-1760
Published Date: 14 July 2016
ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan
Hatakenaka Y, Fernell E, Sakaguchi M, Ninomiya H, Fukunaga I, Gillberg C
Neuropsychiatric Disease and Treatment 2016, 12:1739-1746
Published Date: 14 July 2016
Involvement of upregulation of miR-210 in a rat epilepsy model
Chen L, Zheng H, Zhang S
Neuropsychiatric Disease and Treatment 2016, 12:1731-1737
Published Date: 13 July 2016
Evaluation of oxidant, antioxidant, and S100B levels in patients with conversion disorder
Büyükaslan H, Kandemir SB, Asoğlu M, Kaya H, Gökdemir MT, Karababa İF, Güngörmez F, Kılıçaslan F, Şavik E
Neuropsychiatric Disease and Treatment 2016, 12:1725-1729
Published Date: 13 July 2016
A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults
Cui YH, Zheng Y
Neuropsychiatric Disease and Treatment 2016, 12:1715-1723
Published Date: 11 July 2016
Risk factors for suicide among patients with schizophrenia: a cohort study focused on cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid
Neider D, Lindström LH, Bodén R
Neuropsychiatric Disease and Treatment 2016, 12:1711-1714
Published Date: 11 July 2016
Cortical spreading depression produces a neuroprotective effect activating mitochondrial uncoupling protein-5
Viggiano E, Monda V, Messina A, Moscatelli F, Valenzano A, Tafuri D, Cibelli G, De Luca B, Messina G, Monda M
Neuropsychiatric Disease and Treatment 2016, 12:1705-1710
Published Date: 11 July 2016
A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts
Dell’Osso L, Del Grande C, Gesi C, Carmassi C, Musetti L
Neuropsychiatric Disease and Treatment 2016, 12:1687-1703
Published Date: 11 July 2016
Autism spectrum disorder in adults: diagnosis, management, and health services development
Murphy CM, Wilson CE, Robertson DM, Ecker C, Daly EM, Hammond N, Galanopoulos A, Dud I, Murphy DG, McAlonan GM
Neuropsychiatric Disease and Treatment 2016, 12:1669-1686
Published Date: 7 July 2016
Relationship of attention-deficit/hyperactivity disorder symptom severity with severity of alcohol-related problems in a sample of inpatients with alcohol use disorder
Bozkurt M, Evren C, Umut G, Evren B
Neuropsychiatric Disease and Treatment 2016, 12:1661-1667
Published Date: 7 July 2016
Historical evolution of the concept of anorexia nervosa and relationships with orthorexia nervosa, autism, and obsessive-compulsive spectrum
Dell'Osso L, Abelli M, Carpita B, Pini S, Castellini G, Carmassi C, Ricca V
Neuropsychiatric Disease and Treatment 2016, 12:1651-1660
Published Date: 7 July 2016
Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia
Wada A, Kunii Y, Matsumoto J, Hino M, Nagaoka A, Niwa SI, Yabe H
Neuropsychiatric Disease and Treatment 2016, 12:1645-1650
Published Date: 6 July 2016
Age at diagnosis of autism spectrum disorders: is there an association with socioeconomic status and family self-education about autism?
Hrdlicka M, Vacova M, Oslejskova H, Gondzova V, Vadlejchova I, Kocourkova J, Koutek J, Dudova I
Neuropsychiatric Disease and Treatment 2016, 12:1639-1644
Published Date: 6 July 2016
Risk-factor differences for nonsuicidal self-injury and suicide attempts in Mexican psychiatric patients
Fresán A, Camarena B, González-Castro TB, Tovilla-Zárate CA, Juárez-Rojop IE, López-Narváez L, González-Ramón AE, Hernández-Díaz Y
Neuropsychiatric Disease and Treatment 2016, 12:1631-1637
Published Date: 5 July 2016
5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients
Dong ZQ, Li XR, He L, He G, Yu T, Sun XL
Neuropsychiatric Disease and Treatment 2016, 12:1623-1629
Published Date: 4 July 2016
Effects of Astragalus polysaccharides on memory impairment in a diabetic rat model
Dun C, Liu J, Qiu F, Wu X, Wang Y, Zhao Y, Gu P
Neuropsychiatric Disease and Treatment 2016, 12:1617-1621
Published Date: 1 July 2016
Measuring illness insight in patients with alcohol-related cognitive dysfunction using the Q8 questionnaire: a validation study
Walvoort SJW, van der Heijden PT, Kessels RPC, Egger JIM
Neuropsychiatric Disease and Treatment 2016, 12:1609-1615
Published Date: 1 July 2016
Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression
Harada E, Satoi Y, Kikuchi T, Watanabe K, Alev L, Mimura M
Neuropsychiatric Disease and Treatment 2016, 12:1599-1607
Published Date: 30 June 2016
Prediction of population with Alzheimer's disease in the European Union using a system dynamics model
Tomaskova H, Kuhnova J, Cimler R, Dolezal O, Kuca K
Neuropsychiatric Disease and Treatment 2016, 12:1589-1598
Published Date: 30 June 2016
Parkinson's disease managing reversible neurodegeneration [Corrigendum]
Hinz M, Stein A, Cole T, McDougall B, Westaway M
Neuropsychiatric Disease and Treatment 2016, 12:1587-1588
Published Date: 28 June 2016
Cortisol awakening response in drug-naïve panic disorder
Jakuszkowiak-Wojten K, Landowski J, Wiglusz MS, Cubała WJ
Neuropsychiatric Disease and Treatment 2016, 12:1581-1585
Published Date: 27 June 2016
Mental toughness, sleep disturbances, and physical activity in patients with multiple sclerosis compared to healthy adolescents and young adults
Sadeghi Bahmani D, Gerber M, Kalak N, Lemola S, Clough PJ, Calabrese P, Shaygannejad V, Pühse U, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2016, 12:1571-1579
Published Date: 27 June 2016
Unmet needs of bipolar disorder patients
Hajda M, Prasko J, Latalova K, Hruby R, Ociskova M, Holubova M, Kamaradova D, Mainerova B
Neuropsychiatric Disease and Treatment 2016, 12:1561-1570
Published Date: 24 June 2016
Cognitive status in patients with multiple sclerosis in Lanzarote
Pérez-Martín MY, Eguia-del Rio P, González-Platas M, Jiménez-Sosa A
Neuropsychiatric Disease and Treatment 2016, 12:1553-1559
Published Date: 30 June 2016
Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients
Ociskova M, Prasko J, Latalova K, Kamaradova D, Grambal A
Neuropsychiatric Disease and Treatment 2016, 12:1539-1551
Published Date: 24 June 2016
Aggression in autism spectrum disorder: presentation and treatment options
Fitzpatrick SE, Srivorakiat L, Wink LK, Pedapati EV, Erickson CA
Neuropsychiatric Disease and Treatment 2016, 12:1525-1538
Published Date: 23 June 2016
Monitoring intracranial pressure utilizing a novel pattern of brain multiparameters in the treatment of severe traumatic brain injury
Sun H, Zheng M, Wang Y, Diao Y, Zhao W, Wei Z
Neuropsychiatric Disease and Treatment 2016, 12:1517-1523
Published Date: 23 June 2016
Effect of adjuvant sleep hygiene psychoeducation and lorazepam on depression and sleep quality in patients with major depressive disorders: results from a randomized three-arm intervention
Rahimi A, Ahmadpanah M, Shamsaei F, Cheraghi F, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2016, 12:1507-1515
Published Date: 22 June 2016
A door-to-door survey to estimate the prevalence of Parkinsonism in Pakistan
Khan S, Nabi G, Naeem M, Ali L, Silburn PA, Mellick GD
Neuropsychiatric Disease and Treatment 2016, 12:1499-1506
Published Date: 21 June 2016
Effects of perpetrator identity on suicidality and nonsuicidal self-injury in sexually victimized female adolescents
Unlu G, Cakaloz B
Neuropsychiatric Disease and Treatment 2016, 12:1489-1497
Published Date: 21 June 2016
Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study
Lana F, Sánchez-Gil C, Adroher ND, Pérez V, Feixas G, Martí-Bonany J, Torrens M
Neuropsychiatric Disease and Treatment 2016, 12:1477-1487
Published Date: 21 June 2016
Characterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of three vilazodone studies
Clayton AH, Durgam S, Tang X, Chen C, Ruth A, Gommoll C
Neuropsychiatric Disease and Treatment 2016, 12:1467-1476
Published Date: 21 June 2016
Psychometric properties of the Spanish version of the Clinical Outcomes in Routine Evaluation – Outcome Measure
Trujillo A, Feixas G, Bados A, García-Grau E, Salla M, Medina JC, Montesano A, Soriano J, Medeiros-Ferreira L, Cañete J, Corbella S, Grau A, Lana F, Evans C
Neuropsychiatric Disease and Treatment 2016, 12:1457-1466
Published Date: 21 June 2016
Altered lower leg muscle activation patterns in patients with cerebral palsy during cycling on an ergometer
Alves-Pinto A, Blumenstein T, Turova V, Lampe R
Neuropsychiatric Disease and Treatment 2016, 12:1445-1456
Published Date: 17 June 2016
Deep brain stimulation of pallidal versus subthalamic for patients with Parkinson's disease: a meta-analysis of controlled clinical trials
Xu F, Ma W, Huang Y, Qiu Z, Sun L
Neuropsychiatric Disease and Treatment 2016, 12:1435-1444
Published Date: 22 June 2016
The causes of new-onset epilepsy and seizures in the elderly
Liu S, Yu W, Lü Y
Neuropsychiatric Disease and Treatment 2016, 12:1425-1434
Published Date: 17 June 2016
Body integrity identity disorder crosses culture: case reports in the Japanese and Chinese literature
Blom RM, Vulink NC, van der Wal SJ, Nakamae T, Tan Z, Derks EM, Denys D
Neuropsychiatric Disease and Treatment 2016, 12:1419-1423
Published Date: 16 June 2016
Self-perceived cognitive deficits and their relationship with internalized stigma and quality of life in patients with schizophrenia
Shin YJ, Joo YH, Kim JH
Neuropsychiatric Disease and Treatment 2016, 12:1411-1417
Published Date: 16 June 2016
Anterior cingulate hyperactivations during negative emotion processing among men with schizophrenia and a history of violent behavior
Tikàsz A, Potvin S, Lungu O, Joyal CC, Hodgins S, Mendrek A, Dumais A
Neuropsychiatric Disease and Treatment 2016, 12:1397-1410
Published Date: 15 June 2016
Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression
Zincir S, Öztürk P, Bilgen AE, İzci F, Yükselir C
Neuropsychiatric Disease and Treatment 2016, 12:1389-1396
Published Date: 15 June 2016
Recognized homonymous hemianopsia and delirium during the admission examination leading to diagnosis and appropriate treatment of a new stroke
Tsymbalov KS, Fetkenhour DR
Neuropsychiatric Disease and Treatment 2016, 12:1385-1388
Published Date: 14 June 2016
Early diagnosis and Early Start Denver Model intervention in autism spectrum disorders delivered in an Italian Public Health System service
Devescovi R, Monasta L, Mancini A, Bin M, Vellante V, Carrozzi M, Colombi C
Neuropsychiatric Disease and Treatment 2016, 12:1379-1384
Published Date: 14 June 2016
Abnormal spontaneous regional brain activity in primary insomnia: a resting-state functional magnetic resonance imaging study
Li C, Ma XF, Dong MS, Yin Y, Hua KL, Li M, Li CH, Zhan WF, Li C, Jiang GH
Neuropsychiatric Disease and Treatment 2016, 12:1371-1378
Published Date: 14 June 2016
The effect of ApoE e4 on blood pressure in patients with and without depression
Hestad KA, Engedal K, Whist JE, Farup PG
Neuropsychiatric Disease and Treatment 2016, 12:1365-1370
Published Date: 14 June 2016
Volumetric brain abnormalities in polysubstance use disorder patients
Noyan CO, Kose S, Nurmedov S, Metin B, Darcin AE, Dilbaz N
Neuropsychiatric Disease and Treatment 2016, 12:1355-1363
Published Date: 13 June 2016
Bilateral internal carotid artery dissection associated with prior syphilis: a case report and review of the literature
Marangi A, Moretto G, Cappellari M, Micheletti N, Tomelleri G, Bovi P
Neuropsychiatric Disease and Treatment 2016, 12:1351-1354
Published Date: 10 June 2016
Randomized controlled trials – a matter of design
Spieth PM, Kubasch AS, Penzlin AI, Illigens BM, Barlinn K, Siepmann T
Neuropsychiatric Disease and Treatment 2016, 12:1341-1349
Published Date: 10 June 2016
Investigating analgesic and psychological factors associated with risk of postpartum depression development: a case–control study
Suhitharan T, Pham TPT, Chen H, Assam PN, Sultana R, Han NLR, Tan EC, Sng BL
Neuropsychiatric Disease and Treatment 2016, 12:1333-1339
Published Date: 9 June 2016
Cognitive behavioral therapy for depression in Japanese Parkinson's disease patients: a pilot study
Shinmei I, Kobayashi K, Oe Y, Takagishi Y, Kanie A, Ito M, Takebayashi Y, Murata M, Horikoshi M, Dobkin RD
Neuropsychiatric Disease and Treatment 2016, 12:1319-1331
Published Date: 8 June 2016
The current state of physical activity and exercise programs in German-speaking, Swiss psychiatric hospitals: results from a brief online survey
Brand S, Colledge F, Beeler N, Pühse U, Kalak N, Sadeghi Bahmani D, Mikoteit T, Holsboer-Trachsler E, Gerber M
Neuropsychiatric Disease and Treatment 2016, 12:1309-1317
Published Date: 3 June 2016
Altered intrinsic regional brain spontaneous activity in patients with comitant strabismus: a resting-state functional MRI study
Huang X, Li SH, Zhou FQ, Zhang Y, Zhong YL, Cai FQ, Shao Y, Zeng XJ
Neuropsychiatric Disease and Treatment 2016, 12:1303-1308
Published Date: 3 June 2016
Is the Dissociative Experiences Scale able to identify detachment and compartmentalization symptoms? Factor structure of the Dissociative Experiences Scale in a large sample of psychiatric and nonpsychiatric subjects
Mazzotti E, Farina B, Imperatori C, Mansutti F, Prunetti E, Speranza AM, Barbaranelli C
Neuropsychiatric Disease and Treatment 2016, 12:1295-1302
Published Date: 3 June 2016
Intravenous administration of adipose tissue-derived stem cells enhances nerve healing and promotes BDNF expression via the TrkB signaling in a rat stroke model
Li X, Zheng W, Bai H, Wang J, Wei R, Wen H, Ning H
Neuropsychiatric Disease and Treatment 2016, 12:1287-1293
Published Date: 2 June 2016
Chronic depression treated successfully with novel taping therapy: a new approach to the treatment of depression
Han CH, Hwang HS, Lee YJ, Lee SN, Abanes JJ, Lee BH
Neuropsychiatric Disease and Treatment 2016, 12:1281-1286
Published Date: 1 June 2016
Comparison of clinical features between primary and drug-induced sleep-related eating disorder
Komada Y, Takaesu Y, Matsui K, Nakamura M, Nishida S, Kanno M, Usui A, Inoue Y
Neuropsychiatric Disease and Treatment 2016, 12:1275-1280
Published Date: 26 May 2016
Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?
Sueki A, Suzuki E, Takahashi H, Ishigooka J
Neuropsychiatric Disease and Treatment 2016, 12:1269-1273
Published Date: 23 May 2016
Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
Beyazyüz M, Küfeciler T, Bulut L, Ünsal C, Albayrak Y, Akyol ES, Baykal S, Kuloglu M, Hashimoto K
Neuropsychiatric Disease and Treatment 2016, 12:1261-1268
Published Date: 23 May 2016
Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
Tambucci R, Basti C, Maresca M, Coppola G, Verrotti A
Neuropsychiatric Disease and Treatment 2016, 12:1251-1260
Published Date: 23 May 2016
A functional MRI study of altered spontaneous brain activity pattern in patients with congenital comitant strabismus using amplitude of low-frequency fluctuation
Tan G, Huang X, Zhang Y, Wu AH, Zhong YL, Wu K, Zhou FQ, Shao Y
Neuropsychiatric Disease and Treatment 2016, 12:1243-1250
Published Date: 20 May 2016
Effect of Jian-Pi-Zhi-Dong Decoction on striatal glutamate and γ-aminobutyric acid levels detected using microdialysis in a rat model of Tourette syndrome
Zhang W, Wei L, Yu WJ, Cui X, Liu XF, Wang Q, Wang SM
Neuropsychiatric Disease and Treatment 2016, 12:1233-1242
Published Date: 19 May 2016
Low-dose aripiprazole for refractory burning mouth syndrome
Umezaki Y, Takenoshita M, Toyofuku A
Neuropsychiatric Disease and Treatment 2016, 12:1229-1231
Published Date: 19 May 2016
Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study)
Park YM, Lee BH
Neuropsychiatric Disease and Treatment 2016, 12:1221-1227
Published Date: 17 May 2016
Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizures
Besag FM, Patsalos PN
Neuropsychiatric Disease and Treatment 2016, 12:1215-1220
Published Date: 17 May 2016
Clinical features, comorbidity, and cognitive impairment in elderly bipolar patients
Rise IV, Haro JM, Gjervan B
Neuropsychiatric Disease and Treatment 2016, 12:1203-1213
Published Date: 17 May 2016
A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder
Craig F, Margari F, Legrottaglie AR, Palumbi R, de Giambattista C, Margari L
Neuropsychiatric Disease and Treatment 2016, 12:1191-1202
Published Date: 12 May 2016
Efficacy and motor complications of original and generic levodopa in Parkinson's disease treatment
Kasemsap N, Onsanit S, Chiewthanakul P, Kongbunkiat K, Tanking C, Vorasoot N, Sawanyawisuth K, Tiamkao S
Neuropsychiatric Disease and Treatment 2016, 12:1185-1189
Published Date: 11 May 2016
The role of psychiatrists in diagnosing conversion disorder: a mixed-methods analysis
Kanaan RA, Armstrong D, Wessely S
Neuropsychiatric Disease and Treatment 2016, 12:1181-1184
Published Date: 11 May 2016
Clinical usefulness of hemoencephalography beyond the neurofeedback
Serra-Sala M, Timoneda-Gallart C, Pérez-Álvarez F
Neuropsychiatric Disease and Treatment 2016, 12:1173-1180
Published Date: 11 May 2016
Measuring negative symptoms in patients with schizophrenia: reliability and validity of the Korean version of the Motivation and Pleasure Scale-Self-Report
Kim JS, Jang SK, Park SC, Yi JS, Park JK, Lee JS, Choi KH, Lee SH
Neuropsychiatric Disease and Treatment 2016, 12:1167-1172
Published Date: 11 May 2016
Memory deficit in patients with schizophrenia and posttraumatic stress disorder: relational vs item-specific memory
Jung W, Lee SH
Neuropsychiatric Disease and Treatment 2016, 12:1157-1166
Published Date: 10 May 2016
A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression
Sugawara H, Sakamoto K, Harada T, Shimizu S, Ishigooka J
Neuropsychiatric Disease and Treatment 2016, 12:1151-1156
Published Date: 10 May 2016
The impact of synapsin III gene on the neurometabolite level alterations after single-dose methylphenidate in attention-deficit hyperactivity disorder patients
Başay Ö, Kabukcu Basay B, Alacam H, Ozturk O, Buber A, Gorucu Yilmaz S, Kıroğlu Y, Erdal ME, Herken H
Neuropsychiatric Disease and Treatment 2016, 12:1141-1149
Published Date: 10 May 2016
Absence epilepsy and the CHD2 gene: an adolescent male with moderate intellectual disability, short-lasting psychoses, and an interstitial deletion in 15q26.1–q26.2
Verhoeven WMA, Egger JIM, Knegt AC, Zuydam J, Kleefstra T
Neuropsychiatric Disease and Treatment 2016, 12:1135-1139
Published Date: 10 May 2016
The prevalence and risk factors of stroke in patients with chronic schizophrenia
Liang Y, Huang J, Tian J, Cao Y, Zhang G, Wang C, Cao Y, Li J
Neuropsychiatric Disease and Treatment 2016, 12:1131-1134
Published Date: 9 May 2016
Possible sertraline-induced extrapyramidal adverse effects in an adolescent
Wang LF, Huang JW, Shan SY, Ding JH, Lai JB, Xu Y, Hu SH
Neuropsychiatric Disease and Treatment 2016, 12:1127-1129
Published Date: 6 May 2016
Cognitive deficits in patients with obsessive–compulsive disorder – electroencephalography correlates
Kamaradova D, Hajda M, Prasko J, Taborsky J, Grambal A, Latalova K, Ociskova M, Brunovsky M, Hlustik P
Neuropsychiatric Disease and Treatment 2016, 12:1119-1125
Published Date: 6 May 2016
Spectrum of epilepsy – prevalence, impact, and treatment gap: an epidemiological study from Al-Quseir, Egypt
El-Tallawy HN, Farghaly WM, Rageh TA, Shehata GA, Metwally NA, Badry R, Sayed MA, Abdelwarith AM, Kandil MR, Hamed MA, Mohamed KO, Tohamy AM
Neuropsychiatric Disease and Treatment 2016, 12:1111-1118
Published Date: 12 May 2016
Selecting score types for longitudinal evaluations: the responsiveness of the Comprehensive Developmental Inventory for Infants and Toddlers in children with developmental disabilities
Tsai YP, Tung LC, Lee YC, Wang YL, Yen YS, Chen KL
Neuropsychiatric Disease and Treatment 2016, 12:1103-1109
Published Date: 4 May 2016
Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
Huss M, Sikirica V, Hervas A, Newcorn JH, Harpin V, Robertson B
Neuropsychiatric Disease and Treatment 2016, 12:1085-1101
Published Date: 5 May 2016
Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
Treuer T, Méndez L, Montgomery W, Wu S
Neuropsychiatric Disease and Treatment 2016, 12:1061-1083
Published Date: 3 May 2016
Psychological and behavioral intervention improves the quality of life and mental health of patients suffering from differentiated thyroid cancer treated with postoperative radioactive iodine-131
Wu HX, Zhong H, Xu YD, Xu CP, Zhang Y, Zhang W
Neuropsychiatric Disease and Treatment 2016, 12:1055-1060
Published Date: 2 May 2016
Investigation of facial emotion recognition, alexithymia, and levels of anxiety and depression in patients with somatic symptoms and related disorders
Öztürk A, Kiliç A, Deveci E, Kirpinar i
Neuropsychiatric Disease and Treatment 2016, 12:1047-1053
Published Date: 29 April 2016
Risk factors for pneumonia among patients with Parkinson's disease: a Taiwan nationwide population-based study
Chang YP, Yang CJ, Hu KF, Chao AC, Chang YH, Hsieh KP, Tsai JH, Ho PS, Lim SY
Neuropsychiatric Disease and Treatment 2016, 12:1037-1046
Published Date: 27 April 2016
Anxiety and depression in patients with head and neck cancer: 6-month follow-up study
Wu YS, Lin PY, Chien CY, Fang FM, Chiu NM, Hung CF, Lee Y, Chong MY
Neuropsychiatric Disease and Treatment 2016, 12:1029-1036
Published Date: 27 April 2016
Decision-making deficits in patients with chronic schizophrenia: Iowa Gambling Task and Prospect Valence Learning model
Kim MS, Kang BN, Lim JY
Neuropsychiatric Disease and Treatment 2016, 12:1019-1027
Published Date: 22 April 2016
Investigation of PON1 activity and MDA levels in patients with epilepsy not receiving antiepileptic treatment
Dönmezdil N, Çevik MU, Özdemir HH, Taşin M
Neuropsychiatric Disease and Treatment 2016, 12:1013-1017
Published Date: 22 April 2016
Protective effects of L-glutamine against toxicity of deltamethrin in the cerebral tissue
Varol S, Özdemir HH, Çevik MU, Altun Y, Ibiloğlu I, Ekinci A, Ibiloğlu AO, Balduz M, Arslan D, Tekin R, Aktar F, Aluçlu MU
Neuropsychiatric Disease and Treatment 2016, 12:1005-1011
Published Date: 21 April 2016
Sense of alexithymia in patients with anxiety disorders comorbid with recurrent urticaria
Ogłodek EA, Szota AM, Just MJ, Araszkiewicz A, Szromek AR
Neuropsychiatric Disease and Treatment 2016, 12:995-1004
Published Date: 21 April 2016
The correlation between stress and economic crisis: a systematic review
Mucci N, Giorgi G, Roncaioli M, Fiz Perez J, Arcangeli G
Neuropsychiatric Disease and Treatment 2016, 12:983-993
Published Date: 21 April 2016
White matter alterations related to attention-deficit hyperactivity disorder and COMT val158met polymorphism: children with valine homozygote attention-deficit hyperactivity disorder have altered white matter connectivity in the right cingulum (cingulate gyrus)
Kabukcu Basay B, Buber A, Basay O, Alacam H, Ozturk O, Suren S, Izci Ay O, Acikel C, Agladıoglu K, Erdal ME, Ercan ES, Herken H
Neuropsychiatric Disease and Treatment 2016, 12:969-981
Published Date: 21 April 2016
Diagnostic pitfalls in a young Romanian ranger with an acute psychotic episode
Nagy EE, Rácz A, Urbán E, Terhes G, Berki T, Horváth E, Georgescu AM, Zaharia-Kézdi IE
Neuropsychiatric Disease and Treatment 2016, 12:961-967
Published Date: 3 May 2016
The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis
Fu J, Peng LL, Li XG
Neuropsychiatric Disease and Treatment 2016, 12:951-959
Published Date: 19 April 2016
Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China
Zhang L, Chen Y, Yue L, Liu Q, Montgomery W, Zhi L, Wang W
Neuropsychiatric Disease and Treatment 2016, 12:941-949
Published Date: 20 April 2016
Medication management during electroconvulsant therapy
Zolezzi M
Neuropsychiatric Disease and Treatment 2016, 12:931-939
Published Date: 19 April 2016
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
Montemagni C, Frieri T, Rocca P
Neuropsychiatric Disease and Treatment 2016, 12:917-929
Published Date: 19 April 2016
Olig1 expression pattern in neural cells during rat spinal cord development
Qi Q, Zhang Y, Shen L, Wang R, Zhou J, Lü H, Hu J
Neuropsychiatric Disease and Treatment 2016, 12:909-916
Published Date: 18 April 2016
Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia
Alosaimi FD, Alhabbad AA, Abalhassan MF, Fallata EO, Alzain NM, Alassiry MZ, Haddad BA
Neuropsychiatric Disease and Treatment 2016, 12:897-907
Published Date: 19 April 2016
Shen-Qi-Jie-Yu-Fang exerts effects on a rat model of postpartum depression by regulating inflammatory cytokines and CD4+CD25+ regulatory T cells
Li JY, Zhao RZ, Li XL, Sun WJ, Qu M, Tang QS, Yang XK, Zhang SJ
Neuropsychiatric Disease and Treatment 2016, 12:883-896
Published Date: 15 April 2016
Fear of falling: efficacy of virtual reality associated with serious games in elderly people
Levy F, Leboucher P, Rautureau G, Komano O, Millet B, Jouvent R
Neuropsychiatric Disease and Treatment 2016, 12:877-881
Published Date: 15 April 2016
Olfactory dysfunction in Alzheimer’s disease
Zou YM, Lu D, Liu LP, Zhang HH, Zhou YY
Neuropsychiatric Disease and Treatment 2016, 12:869-875
Published Date: 15 April 2016
Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia
Urban-Kowalczyk M, Śmigielski J, Strzelecki D
Neuropsychiatric Disease and Treatment 2016, 12:863-868
Published Date: 15 April 2016
Altered intra- and interregional synchronization in relapsing–remitting multiple sclerosis: a resting-state fMRI study
Wu L, Zhang Y, Zhou F, Gao L, He L, Zeng X, Gong H
Neuropsychiatric Disease and Treatment 2016, 12:853-862
Published Date: 15 April 2016
Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder
Medhasi S, Pasomsub E, Vanwong N, Ngamsamut N, Puangpetch A, Chamnanphon M, Hongkaew Y, Limsila P, Pinthong D, Sukasem C
Neuropsychiatric Disease and Treatment 2016, 12:843-851
Published Date: 13 April 2016
Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
Guerdjikova AI, Mori N, Casuto LS, McElroy SL
Neuropsychiatric Disease and Treatment 2016, 12:833-841
Published Date: 18 April 2016
The influence of childhood abuse, adult life events, and affective temperaments on the well-being of the general, nonclinical adult population
Kanai Y, Takaesu Y, Nakai Y, Ichiki M, Sato M, Matsumoto Y, Ishikawa J, Ono Y, Murakoshi A, Tanabe H, Kusumi I, Inoue T
Neuropsychiatric Disease and Treatment 2016, 12:823-832
Published Date: 12 April 2016
Patients with depression display cytokine levels in serum and cerebrospinal fluid similar to patients with diffuse neurological symptoms without a defined diagnosis
Hestad KA, Engedal K, Whist JE, Aukrust P, Farup PG, Mollnes TE, Ueland T
Neuropsychiatric Disease and Treatment 2016, 12:817-822
Published Date: 13 April 2016
Relationship between quality of life and restless legs syndrome among a community-dwelling population in Japan
Kubo K, Sugawara N, Kaneda A, Takahashi I, Nakamura K, Nakaji S, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2016, 12:809-815
Published Date: 12 April 2016
Sleep deprivation disturbed regional brain activity in healthy subjects: evidence from a functional magnetic resonance-imaging study
Wang L, Chen Y, Yao Y, Pan Y, Sun Y
Neuropsychiatric Disease and Treatment 2016, 12:801-807
Published Date: 12 April 2016
Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients
Novick D, Montgomery W, Aguado J, Peng XM, Haro JM
Neuropsychiatric Disease and Treatment 2016, 12:795-800
Published Date: 11 April 2016
Suicidal behavior and self-harm in girls with eating disorders
Koutek J, Kocourkova J, Dudova I
Neuropsychiatric Disease and Treatment 2016, 12:787-793
Published Date: 11 April 2016
Virtual reality for the treatment of posttraumatic disorders
Moraes TM, de Andrade AF, Paiva WS
Neuropsychiatric Disease and Treatment 2016, 12:785-786
Published Date: 7 April 2016
Does amantadine induce acute psychosis? A case report and literature review
Xu WJ, Wei N, Xu Y, Hu SH
Neuropsychiatric Disease and Treatment 2016, 12:781-783
Published Date: 6 April 2016
Uncovering the etiology of conversion disorder: insights from functional neuroimaging [Corrigendum]
Ejareh dar M, Kanaan RAA
Neuropsychiatric Disease and Treatment 2016, 12:779-780
Published Date: 6 April 2016
Positron emission tomography in patients with psychogenic non-epileptic seizures
McGonigal A, Arthuis M, Micoulaud-Franchi JA, Bartolomei F, Guedj E
Neuropsychiatric Disease and Treatment 2016, 12:777-778
Published Date: 5 April 2016
Parkinson’s disease managing reversible neurodegeneration
Hinz M, Stein A, Cole T, McDougall B, Westaway M
Neuropsychiatric Disease and Treatment 2016, 12:763-775
Published Date: 5 April 2016
A meta-synthesis on parenting a child with autism
Ooi KL, Ong YS, Jacob SA, Khan TM
Neuropsychiatric Disease and Treatment 2016, 12:745-762
Published Date: 5 April 2016
Demographic variables, clinical aspects, and medicolegal implications in a population of patients with adjustment disorder
Anastasia A, Colletti C, Cuoco V, Quartini A, Urso S, Rinaldi R, Bersani G
Neuropsychiatric Disease and Treatment 2016, 12:737-743
Published Date: 1 April 2016
Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review
Fornaro M, De Berardis D, Koshy AS, Perna G, Valchera A, Vancampfort D, Stubbs B
Neuropsychiatric Disease and Treatment 2016, 12:719-735
Published Date: 31 March 2016
Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report
Zhang B, Zhao Y, Liu J, Li L, Shan J, Zhao D, Yan C
Neuropsychiatric Disease and Treatment 2016, 12:713-717
Published Date: 29 March 2016
Traumatic posterior communicating artery-cavernous fistula, angioarchitecture, and possible pathogenesis: a case report and literature review
Du B, Zhang M, Liu QL, Shen J, Wang YY
Neuropsychiatric Disease and Treatment 2016, 12:707-711
Published Date: 30 March 2016
A family-oriented therapy program for youths with substance abuse: long-term outcomes related to relapse and academic or social status
Wang LJ, Lu SF, Chong MY, Chou WJ, Hsieh YL, Tsai TN, Chen C, Lee YH
Neuropsychiatric Disease and Treatment 2016, 12:699-706
Published Date: 30 March 2016
Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia
Cheng MF, Gu HY, Zheng LR, Wang HL, Zhong ZY, Wen SL
Neuropsychiatric Disease and Treatment 2016, 12:695-697
Published Date: 29 March 2016
Brain-derived neurotrophic factor modulates immune reaction in mice with peripheral nerve xenotransplantation
Yu X, Lu L, Liu Z, Yang T, Gong X, Ning Y, Jiang Y
Neuropsychiatric Disease and Treatment 2016, 12:685-694
Published Date: 29 March 2016
The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
Yanartas O, Kani HT, Bicakci E, Kilic I, Banzragch M, Acikel C, Atug O, Kuscu K, Imeryuz N, Akin H
Neuropsychiatric Disease and Treatment 2016, 12:673-683
Published Date: 24 March 2016
Quality of life and parental styles assessed by adolescents suffering from inflammatory bowel diseases and their parents
Jelenova D, Prasko J, Ociskova M, Latalova K, Karaskova E, Hruby R, Kamaradova D, Mihal V
Neuropsychiatric Disease and Treatment 2016, 12:665-672
Published Date: 23 March 2016
One patient with Sjogren’s syndrome presenting schizophrenia-like symptoms
Lin CE
Neuropsychiatric Disease and Treatment 2016, 12:661-663
Published Date: 22 March 2016
A prosocial online game for social cognition training in adolescents with high-functioning autism: an fMRI study
Chung US, Han DH, Shin YJ, Renshaw PF
Neuropsychiatric Disease and Treatment 2016, 12:651-660
Published Date: 17 March 2016
Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
Takeyoshi K, Kurita M, Nishino S, Teranishi M, Numata Y, Sato T, Okubo Y
Neuropsychiatric Disease and Treatment 2016, 12:641-649
Published Date: 15 March 2016
Cognitive behavioral therapy in pharmacoresistant obsessive–compulsive disorder
Vyskocilova J, Prasko J, Sipek J
Neuropsychiatric Disease and Treatment 2016, 12:625-639
Published Date: 14 March 2016
Effects of intracerebral hemorrhage on 5-hydroxymethylcytosine modification in mouse brains
Tang YL, Han S, Asakawa T, Luo YH, Han X, Xiao BG, Dong Q, Wang L
Neuropsychiatric Disease and Treatment 2016, 12:617-624
Published Date: 15 March 2016
No association between BDNFVal66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population
Umehara H, Numata S, Kinoshita M, Watanabe S, Nakaaki S, Sumitani S, Ohmori T
Neuropsychiatric Disease and Treatment 2016, 12:611-615
Published Date: 11 March 2016
Identification of a seasonal pattern to brain metastases
Sakellakis M, Koutras A, Pittaka M, Kardamakis D, Kalofonou M, Kalofonos HP, Spyropoulou D
Neuropsychiatric Disease and Treatment 2016, 12:609-610
Published Date: 7 March 2016
Validity and test–retest reliability of the Persian version of the Montgomery–Asberg Depression Rating Scale
Ahmadpanah M, Sheikhbabaei M, Haghighi M, Roham F, Jahangard L, Akhondi A, Sadeghi Bahmani D, Bajoghli H, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2016, 12:603-607
Published Date: 7 March 2016
Brain oscillations in bipolar disorder and lithium-induced changes
Atagün Mİ
Neuropsychiatric Disease and Treatment 2016, 12:589-601
Published Date: 7 March 2016
Occurrence of ADHD in parents of ADHD children in a clinical sample
Starck M, Grünwald J, Schlarb AA
Neuropsychiatric Disease and Treatment 2016, 12:581-588
Published Date: 3 March 2016
Attention deficit hyperactivity disorder and disordered eating behaviors: links, risks, and challenges faced
Ptacek R, Stefano GB, Weissenberger S, Akotia D, Raboch J, Papezova H, Domkarova L, Stepankova T, Goetz M
Neuropsychiatric Disease and Treatment 2016, 12:571-579
Published Date: 3 March 2016
Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study
Petrò E, Ruffini E, Cappuccio M, Guerini V, Belotti G, Fascendini S, Licini C, Marcassa C
Neuropsychiatric Disease and Treatment 2016, 12:559-569
Published Date: 2 March 2016
The noradrenergic paradox: implications in the management of depression and anxiety
Montoya A, Bruins R, Katzman MA, Blier P
Neuropsychiatric Disease and Treatment 2016, 12:541-557
Published Date: 1 March 2016
Assistive technologies for managing language disorders in dementia
Klimova B, Maresova P, Kuca K
Neuropsychiatric Disease and Treatment 2016, 12:533-540
Published Date: 29 February 2016
The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
Li G, Wang X, Ma D
Neuropsychiatric Disease and Treatment 2016, 12:523-531
Published Date: 29 February 2016
Severe water intoxication and secondary depressive syndrome in relation to delusional infestation
Lai J, Lu Q, Xu Y, Hu S
Neuropsychiatric Disease and Treatment 2016, 12:517-521
Published Date: 29 February 2016
Association between sociodemographic characteristics and anxiety levels of violence-exposed patients admitted to emergency clinic
Hocagil H, Izci F, Hocagil AC, Findikli E, Korkmaz S, Koc MI
Neuropsychiatric Disease and Treatment 2016, 12:511-516
Published Date: 26 February 2016
Intelligence quotient discrepancy indicates levels of motor competence in preschool children at risk for developmental delays
Yu TY, Chen KL, Chou W, Yang SH, Kung SC, Lee YC, Tung LC
Neuropsychiatric Disease and Treatment 2016, 12:501-510
Published Date: 26 February 2016
Tetrabenazine-induced oculogyric crisis – a rare complication in the treatment of Gilles de la Tourette syndrome
Janik P, Figura M
Neuropsychiatric Disease and Treatment 2016, 12:497-499
Published Date: 25 February 2016
Suvorexant: a promising, novel treatment for insomnia
Lee-Iannotti JK, Parish JM
Neuropsychiatric Disease and Treatment 2016, 12:491-495
Published Date: 25 February 2016
Financial stress during medical residency training: an experience from Iran
Zamani M, Zamani V
Neuropsychiatric Disease and Treatment 2016, 12:487-489
Published Date: 25 February 2016
Medical management of epileptic seizures: challenges and solutions
Sarma AK, Khandker N, Kurczewski L, Brophy GM
Neuropsychiatric Disease and Treatment 2016, 12:467-485
Published Date: 24 February 2016
A voxel-based morphometric study of age- and sex-related changes in white matter volume in the normal aging brain
Liu H, Wang L, Geng Z, Zhu Q, Song Z, Chang R, Lv H
Neuropsychiatric Disease and Treatment 2016, 12:453-465
Published Date: 24 February 2016
Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease
Guo YJ, Wang LN, Zhu MW, Zhang HH, Hu YZ, Han ZT, Liu J, Zhao WQ, Wang DX
Neuropsychiatric Disease and Treatment 2016, 12:445-452
Published Date: 26 February 2016
Development and validation of the Thai version of the 4 ‘A’s Test for delirium screening in hospitalized elderly patients with acute medical illnesses
Kuladee S, Prachason T
Neuropsychiatric Disease and Treatment 2016, 12:437-443
Published Date: 24 February 2016
Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Minami Y, Ozeki Y, Okamoto K, Sagae T, Someya T
Neuropsychiatric Disease and Treatment 2016, 12:427-436
Published Date: 24 February 2016
Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone
de Biase S, Valente M, Gigli GL
Neuropsychiatric Disease and Treatment 2016, 12:417-425
Published Date: 23 February 2016
The investigation of factors related to suicide attempts in Southeastern Turkey
Okan Ibiloglu A, Atli A, Demir S, Gunes M, Kaya MC, Bulut M, Sir A
Neuropsychiatric Disease and Treatment 2016, 12:407-416
Published Date: 23 February 2016
An Internet-based program for depression using activity and physiological sensors: efficacy, expectations, satisfaction, and ease of use
Botella C, Mira A, Moragrega I, García-Palacios A, Bretón-López J, Castilla D, Riera López del Amo A, Soler C, Molinari G, Quero S, Guillén-Botella V, Miralles I, Nebot S, Serrano B, Majoe D, Alcañiz M, Baños RM
Neuropsychiatric Disease and Treatment 2016, 12:393-406
Published Date: 23 February 2016
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
Novick D, Montgomery W, Haro JM, Moneta MV, Zhu G, Yue L, Hong J, Dueñas H, Brugnoli R
Neuropsychiatric Disease and Treatment 2016, 12:383-392
Published Date: 23 February 2016
DSM-5 PTSD and posttraumatic stress spectrum in Italian emergency personnel: correlations with work and social adjustment
Carmassi C, Gesi C, Simoncini M, Favilla L, Massimetti G, Olivieri MC, Conversano C, Santini M, Dell’Osso L
Neuropsychiatric Disease and Treatment 2016, 12:375-381
Published Date: 18 February 2016
Global economic burden of schizophrenia: a systematic review
Chong HY, Teoh SL, Wu DBC, Kotirum S, Chiou CF, Chaiyakunapruk N
Neuropsychiatric Disease and Treatment 2016, 12:357-373
Published Date: 16 February 2016
Sexual dysfunction, mood, anxiety, and personality disorders in female patients with fibromyalgia
Kayhan F, Küçük A, Satan Y, İlgün E, Arslan S, İlik F
Neuropsychiatric Disease and Treatment 2016, 12:349-355
Published Date: 16 February 2016
Traumatic brain injury-induced sleep disorders
Viola-Saltzman M, Musleh C
Neuropsychiatric Disease and Treatment 2016, 12:339-348
Published Date: 15 February 2016
Preliminary report of improved sleep quality in patients with dry eye disease after initiation of topical therapy
Ayaki M, Toda I, Tachi N, Negishi K, Tsubota K
Neuropsychiatric Disease and Treatment 2016, 12:329-337
Published Date: 16 February 2016
Strategies to improve anxiety and depression in patients with COPD: a mental health perspective
Tselebis A, Pachi A, Ilias I, Kosmas E, Bratis D, Moussas G, Tzanakis N
Neuropsychiatric Disease and Treatment 2016, 12:297-328
Published Date: 9 February 2016
Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges
Williams AE, Giust JM, Kronenberger WG, Dunn DW
Neuropsychiatric Disease and Treatment 2016, 12:287-296
Published Date: 9 February 2016
Recruiting for research studies using online public advertisements examples from research in affective disorders
Wise T, Arnone D, Marwood L, Zahn R, Lythe KE, Young AH
Neuropsychiatric Disease and Treatment 2016, 12:279-285
Published Date: 5 February 2016
Chronic organophosphate-induced neuropsychiatric disorder: a case report
Ghimire SR, Parajuli S
Neuropsychiatric Disease and Treatment 2016, 12:275-277
Published Date: 4 February 2016
Depot-medication compliance for patients with psychotic disorders: the importance of illness insight and treatment motivation
Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT, Mulder CL
Neuropsychiatric Disease and Treatment 2016, 12:269-274
Published Date: 3 February 2016
Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis
Ueda S, Sakayori T, Omori A, Fukuta H, Kobayashi T, Ishizaka K, Saijo T, Okubo Y
Neuropsychiatric Disease and Treatment 2016, 12:265-268
Published Date: 2 February 2016
Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
Santamato A
Neuropsychiatric Disease and Treatment 2016, 12:251-263
Published Date: 27 January 2016
Electroencephalogram characteristics in patients with chronic fatigue syndrome
Wu T, Qi X, Su Y, Teng J, Xu X
Neuropsychiatric Disease and Treatment 2016, 12:241-249
Published Date: 28 January 2016
Mania following ketamine abuse
Lu YY, Lin CH, Lane HY
Neuropsychiatric Disease and Treatment 2016, 12:237-239
Published Date: 27 January 2016
Examining Dark Triad traits in relation to mental toughness and physical activity in young adults
Sabouri S, Gerber M, Sadeghi Bahmani D, Lemola S, Clough PJ, Kalak N, Shamsi M, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2016, 12:229-235
Published Date: 27 January 2016
cAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in rats
Liu X, Guo H, Sayed MDSOM, Lu Y, Yang T, Zhou D, Chen Z, Wang H, Wang C, Xu J
Neuropsychiatric Disease and Treatment 2016, 12:219-227
Published Date: 21 January 2016
Update on eating disorders: current perspectives on avoidant/restrictive food intake disorder in children and youth
Norris ML, Spettigue WJ, Katzman DK
Neuropsychiatric Disease and Treatment 2016, 12:213-218
Published Date: 19 January 2016
Abnormal resting-state functional connectivity within the default mode network subregions in male patients with obstructive sleep apnea
Li HJ, Nie X, Gong HH, Zhang W, Nie S, Peng DC
Neuropsychiatric Disease and Treatment 2016, 12:203-212
Published Date: 19 January 2016
A 5-year retrospective study of demographic, anamnestic, and clinical factors related to psychiatric hospitalizations of adolescent patients
Di Lorenzo R, Cimino N, Di Pietro E, Pollutri G, Neviani V, Ferri P
Neuropsychiatric Disease and Treatment 2016, 12:191-201
Published Date: 18 January 2016
Psychogenic nonepileptic seizures as a manifestation of psychological distress associated with undiagnosed autism spectrum disorder
Miyawaki D, Iwakura Y, Seto T, Kusaka H, Goto A, Okada Y, Asada N, Yanagihara E, Inoue K
Neuropsychiatric Disease and Treatment 2016, 12:185-189
Published Date: 18 January 2016
The differences in temperament–character traits, suicide attempts, impulsivity, and functionality levels of patients with bipolar disorder I and II
Izci F, Fındıklı EK, Zincir S, Zincir SB, Koc MI
Neuropsychiatric Disease and Treatment 2016, 12:177-184
Published Date: 18 January 2016
The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups
Gerez M, Suárez E, Serrano C, Castanedo L, Tello A
Neuropsychiatric Disease and Treatment 2016, 12:159-175
Published Date: 18 January 2016
Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt
El-Tallawy HN, Farghaly WM, Badry R, Metwally NA, Shehata GA, Rageh TA, El Hamed MA, Kandil MR
Neuropsychiatric Disease and Treatment 2016, 12:155-158
Published Date: 13 January 2016
Uncovering the etiology of conversion disorder: insights from functional neuroimaging
Ejareh dar M, Kanaan RAA
Neuropsychiatric Disease and Treatment 2016, 12:143-153
Published Date: 13 January 2016
Incidence and risk factors of postoperative delirium in elderly patients undergoing transurethral resection of prostate: a prospective cohort study
Xue P, Wu ZY, Wang KP, Tu CQ, Wang XB
Neuropsychiatric Disease and Treatment 2016, 12:137-142
Published Date: 12 January 2016
Higher emotional intelligence is related to lower test anxiety among students
Ahmadpanah M, Keshavarz M, Haghighi M, Jahangard L, Bajoghli H, Sadeghi Bahmani D, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2016, 12:133-136
Published Date: 12 January 2016
Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review
Zhang LL, Li JT, Zhao YJ, Su YA, Si TM
Neuropsychiatric Disease and Treatment 2016, 12:113-131
Published Date: 11 January 2016
Synesthetic associations and psychosensory symptoms of temporal epilepsy
Neckar M, Bob P
Neuropsychiatric Disease and Treatment 2016, 12:109-112
Published Date: 11 January 2016
Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics
de Bartolomeis A, Fagiolini A, Vaggi M, Vampini C
Neuropsychiatric Disease and Treatment 2016, 12:99-108
Published Date: 11 January 2016
Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
Harada E, Shirakawa O, Satoi Y, Marangell LB, Escobar R
Neuropsychiatric Disease and Treatment 2016, 12:89-97
Published Date: 11 January 2016
Optimal management of ADHD in older adults
Torgersen T, Gjervan B, Lensing MB, Rasmussen K
Neuropsychiatric Disease and Treatment 2016, 12:79-87
Published Date: 8 January 2016
Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study
Zhang H, Li H, Liu Y, Wu C, Wu Q, Nuamah I, Shi J, Xie S, Wang G, Gopal S
Neuropsychiatric Disease and Treatment 2016, 12:69-77
Published Date: 8 January 2016
Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
Karson C, Duffy RA, Eramo A, Nylander AG, Offord SJ
Neuropsychiatric Disease and Treatment 2016, 12:57-67
Published Date: 6 January 2016
Affective network and default mode network in depressive adolescents with disruptive behaviors
Kim SM, Park SY, Kim YI, Son YD, Chung US, Min KJ, Han DH
Neuropsychiatric Disease and Treatment 2016, 12:49-56
Published Date: 31 December 2015
Computer task performance by subjects with Duchenne muscular dystrophy
Malheiros SRP, da Silva TD, Favero FM, de Abreu LC, Fregni F, Ribeiro DC, de Mello Monteiro CB
Neuropsychiatric Disease and Treatment 2016, 12:41-48
Published Date: 30 December 2015
Use of antidepressants in the treatment of major depressive disorder in primary care during a period of economic crisis
Sicras-Mainar A, Navarro-Artieda R
Neuropsychiatric Disease and Treatment 2016, 12:29-40
Published Date: 30 December 2015
Influence of hypothyroidism on renal function of lithium-treated patients
Lozano R, Marín R, Santacruz MJ
Neuropsychiatric Disease and Treatment 2016, 12:25-27
Published Date: 23 December 2015
Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study
Li HF, Turkoz I, Zhang F
Neuropsychiatric Disease and Treatment 2016, 12:15-24
Published Date: 21 December 2015
Early visual processing for low spatial frequency fearful face is correlated with cortical volume in patients with schizophrenia
Lee JS, Park G, Song MJ, Choi KH, Lee SH
Neuropsychiatric Disease and Treatment 2016, 12:1-14
Published Date: 22 December 2015